EMvision Medical Devices Ltd
ASX:EMV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EMvision Medical Devices Ltd
Cash from Financing Activities
EMvision Medical Devices Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Financing Activities
AU$13m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Somnomed Ltd
ASX:SOM
|
Cash from Financing Activities
-AU$1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Financing Activities
-AU$1.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Financing Activities
-AU$337.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-11%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Financing Activities
AU$17.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
29%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Cash from Financing Activities
-AU$1.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.
See Also
What is EMvision Medical Devices Ltd's Cash from Financing Activities?
Cash from Financing Activities
13m
AUD
Based on the financial report for Dec 31, 2025, EMvision Medical Devices Ltd's Cash from Financing Activities amounts to 13m AUD.
What is EMvision Medical Devices Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
8%
Over the last year, the Cash from Financing Activities growth was -14%.
